Class II · Moderate risk Ongoing
Azelastine HCl Ophthalmic Solution
Reason Lack of Assurance of Sterility
Azelastine HCl Nasal Solution
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.
What was recalled
Azelastine HCl Nasal Solution, 0.1 %, 137 mcg/spray, 30 mL bottle (200 Metered Sprays), Rx only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, NDC 60505-0833-5.
- Recalling firm
- Apotex Corp.
- NDC code
- 60505-0833-5
- Origin
- FL, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1667-2012
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Azelastine recalls
See all
Class II · Moderate risk Ongoing
Azelastine Hydrochloride Nasal Spray
Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class II · Moderate risk Terminated
Dymista
Reason Defective Container: Potential for broken glass in the neck area of the glass bottles.
Class III · Low risk Terminated
Azelastine HCl Ophthalmic Solution 0.05%
Reason Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide
Class II · Moderate risk Terminated
Dymista
Reason Presence of foreign substance: Potential for glass in the neck area of the glass bottles.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.